• Akshay Anand M.
  • M.P. Venkatesh
  • Pramod Kumar T.M.


The past decade has witnessed rapid advancement in telecommunication and computer technologies. The smart phone is one result of that technological development and has been adopted by hundreds of millions of people worldwide. Innovators in the medical device industry quickly recognized the potential to use smartphones to expand the capabilities of healthcare professionals via mobile medical applications (apps) resident on these devices. These apps raise unique challenges for regulation by the drug regulatory authorities worldwide including the Food and Drug Administration (FDA), European Medical Association (EMA) etc. The focus of this article is to shed light on the current trends and future aspects of the regulatory framework implied on the Mobile Health (mHealth).

Keywords: Mobile Health, mHealth, Mobile Health Apps, Mobile Medical Apps.


Download data is not yet available.


1. Bruce A. MacFarlane, FDA Regulations of Mobile Medical Apps [Internet]. USA: NAMSA White Paper; 2014 July [cited 2015 Nov 3]. Available from:
2. GSMA mHealth. ‘mHealth and the EU regulatory framework for medical devices’ [Internet]. United Kingdom: GSMA mHealth Magazine; 2014 [cited 2015 Nov 7] Available from:
3. US Food & Drug Administration [Internet]. United States: FDA Guidance Document 1741 – Mobile Medical Applications: Guidance for Industry and Food and Drug Administration Staff; 2015 April [cited 2015 Oct 25]. Available from:
4. Vollebregt E. Regulation of Medical Apps FDA and EU. [Internet]. JHW Editorial Info - Note 270711; 2011 [Cited 2015 Oct 27]. Available from:
5. PwC Network. ‘How Supportive is the regulatory framework for mobile health applications?’ [Internet]. Japan: mHealth Insights - PwC Network; 2013 Jan [cited 2015 Nov 4] Available from:
6. D4 Research [Internet]. United Kingdom: ‘Regulation of health apps: a practical guide’, D4 Research; 2012 Jan [cited 2015 Nov 11] Available from:
463 Views | 546 Downloads
How to Cite
M., A. A., M. Venkatesh, and P. K. T.M. “GLOBAL REGULATORY APPROACH TOWARDS M-HEALTH”. International Journal of Drug Regulatory Affairs, Vol. 4, no. 1, Feb. 2018, pp. 6-12, doi:10.22270/ijdra.v4i1.176.